Goldman Sachs’s STAAR Surgical STAA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2020
Q3
Sell
-5,000
Closed -$308K 5530
2020
Q2
$308K Buy
+5,000
New +$204K ﹤0.01% 4618
2019
Q4
Sell
-20,000
Closed -$516K 5398
2019
Q3
$516K Buy
+20,000
New +$608K ﹤0.01% 4435
2015
Q2
Sell
-94,500
Closed -$702K 7426
2015
Q1
$702K Buy
+94,500
New +$691K ﹤0.01% 4806

Other funds holding STAA

Goldman Sachs's STAA Position: Q2 2026 in Review

Goldman Sachs increased its STAAR Surgical (STAA) stake by 101% in Q2 2026, buying an estimated $30M and bringing the position to 2,150,809 shares worth $61.7M. The position accounts for 0.01% of the portfolio, ranked #1628.

Goldman Sachs first reported a position in STAA in Q2 2013 and has held it in 49 quarters since. 200 funds tracked by Wall St. Rank hold STAA as of Q2 2026.

  • Goldman Sachs held 2,150,809 shares of STAAR Surgical worth $61.7M as of Q2 2026.
  • Goldman Sachs bought 1,080,870 STAAR Surgical shares in Q2 2026, an estimated $30M.
  • STAAR Surgical made up 0.01% of Goldman Sachs's portfolio in Q2 2026, its #1628 holding.
  • Goldman Sachs first reported a position in STAAR Surgical in Q2 2013 and has held it in 49 quarters since.
  • 200 funds tracked by Wall St. Rank held STAAR Surgical as of Q2 2026.

Based on Goldman Sachs's 13F filing for Q2 2026, filed 14 Aug 2026.